resistanceBio

resistanceBio is a precision oncology drug discovery company that harnesses evolution to overcome and find cures to treatment-resistant cancer.

[Nathan Reticker-Flynn @RetickerFlynn]

Tumors spread to lymph nodes before they metastasize to distant tissues, but for over a century scientists have debated whether this matters. It does. Check out our paper online now @CellCellPress @CellPressNews
https://t.co/WLPnoPtFhN

1/15

[Michalina Janiszewska @janiszewska_lab]

New in cell cycle - CDC7 and CDK1 perform functionally redundant roles during G1/S transition. Great work by @JanekSuski et al. @Nature 👇👇

[Michalina Janiszewska @janiszewska_lab]

Postdoc job alert: Interested in deciphering brain tumor ecosystem / developing in vivo models of GBM to study clonal interactions and tumor microenvironment / mapping spatial organization of cancer tissue? Join us! DM or email me to learn more. https://t.co/MVeVMgLpMx

[Jake Scott @CancerConnector]

While I wasn't his primary caregiver, I was lucky to get to know Chris, as fine a human being as I've known. I consider myself doubly lucky to know his family and to be supported by their foundation for our labs work in #EwingsSarcoma.

#endcancer

https://t.co/ppfaFPlYjK

[resistanceBio @resistanceBio]

Our first Twitter Space is now live, join us:
https://t.co/ga0Bz4ctK5
Ask us any questions at #LatrCANCER

[resistanceBio @resistanceBio]

Don't miss our first Twitter Spaces Chat on Treatment Resistant cancer TONIGHT at 5 p.m. PT/8 p.m. ET! Lindsay and Manasa from rBio will now be joining us in place of Michalina!👇🧬
https://t.co/ga0Bz4d1zD
#LatrCancer #CancerResearch

[resistanceBio @resistanceBio]

We congratulate @cncurtis, a critical member of our advisory board, for her groundbreaking research on tumor evolution!

[Steven Artandi, MD, PhD @SCIDirector]

Congratulation to @cncurtis for receiving the @AACR Award for Outstanding Achievement in Basic Cancer Research. Curtis is being honored for her paradigm-shifting research on tumor evolution. https://t.co/ewcTYzXF6W

[resistanceBio @resistanceBio]

Next Monday, April 11th, 5pm/8pm! Don't forget to join us in our discussion on Treatment-resistant cancer! Click on the link below to enter the chat room directly: https://t.co/ga0Bz4ctK5

[resistanceBio @resistanceBio]

Next Monday, April 11th, 5pm/8pm! Don't forget to join us in our discussion on Treatment-resistant cancer! Click on the link below to enter the room directly: https://t.co/ga0Bz4ctK5
@CancerConnector @n8pennell
#CancerResearch #AACR

[resistanceBio @resistanceBio]

Our live Twitter Space audio chat is just around the corner! In collaboration with some of our Advisory Board members @CancerConnector @n8pennell @janiszewska_lab, we will discuss the state of treatment resistance and our ideas for combating it. 🧬👇#cancerresearch #aacr22

[resistanceBio @resistanceBio]

@ATrotmanGrant Thanks for spreading the word!

[resistanceBio @resistanceBio]

@Dagim26 Thank you for spreading the word!

[resistanceBio @resistanceBio]

Our live Twitter Space audio chat is just around the corner! In collaboration with some of our Advisory Board members @CancerConnector @n8pennell @janiszewska_lab, we will discuss the state of treatment resistance and our ideas for combating it. 🧬👇#cancerresearch #aacr22

[resistanceBio @resistanceBio]

@SingleCellMedia Hi @SingleCellMedia! Thank you for the retweet 🧬

[resistanceBio @resistanceBio]

@cncurtis, a valuable member of our Advisory Board, concluded #AACRevol22 with a powerful presentation on charting genotype to phenotype maps of tumorigenesis.

[resistanceBio @resistanceBio]

A great presentation by @nicholas_navin about decoding breast cancer evolution with single cell genomics and his research around the Human Breast Cell Atlas project. #AACRevol22

[AACR @AACR]

Unraveling cancer evolution with single cell genomics:
This award lecture by Nicholas E. Navin, PhD— recipient of the 2021 AACR Award for Outstanding Achievement in Basic Cancer Research— is now available. #AACR21
https://t.co/bQFlvl7bld

[resistanceBio @resistanceBio]

Great talk from @LambAlastair: Characterizing the spatial infrastructure of benign and malignant cancer
#AACRevol22

[resistanceBio @resistanceBio]

Starting our day with @mehdiDamaghi discussing Selection for a glycolytic phenotype #AACRevol22

[Sandy Anderson @ara_anderson]

Next up is friend and former @MoffittResearch colleague @mehdiDamaghi presenting: Selection for a glycolytic phenotype #AACRevol22 Mehdi recently started a new lab at @stonybrooku

[resistanceBio @resistanceBio]

Plenary session 5 continues with our very own chairman of our Advisory Board, @CancerConnector, presenting cancer as an adaptive system which can be modeled (and controlled?) by evolutionary game theory model. #AACRevol22 #lcsm

[resistanceBio @resistanceBio]

@luddyka @KenoMentor Thanks @luddyka! It would be our pleasure to connect and answer any questions you may have!

[resistanceBio @resistanceBio]

Before the 3:15 break in Plenary Session 5, @sydshaffer discusses Single-cell analysis of drug resistance, cellular memory, and plasticity in cancer. Would love to have her as a guest speaker in one of our upcoming Twitter Spaces chats! #AACRevol22